Mesa Laboratories, Inc. (MLAB) Financial Ratios
30 years of historical data (1997–2026) · Technology · Hardware, Equipment & Parts
EV/EBITDA
↓
14.09
↓-51% vs avg
5yr avg: 28.54
30Y Low4.3·High51.5
P/FCF
↓
12.27
↓-49% vs avg
5yr avg: 24.00
30Y Low7.2·High40.0
P/B Ratio
↓
2.84
↓-14% vs avg
5yr avg: 3.31
30Y Low1.3·High8.4
ROE
↑
3.9%
↓+121% vs avg
5yr avg: -18.2%
30Y Low-94%·High22%
Debt/EBITDA
↓
2.16
↓-55% vs avg
5yr avg: 4.78
30Y Low0.2·High7.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
MLAB Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Mesa Laboratories, Inc. trades at 78.6x earnings, 87% below its 5-year average of 609.7x, sitting at the 96th percentile of its historical range. Compared to the Technology sector median P/E of 29.0x, the stock trades at a premium of 171%. On a free-cash-flow basis, the stock trades at 12.3x P/FCF, 49% below the 5-year average of 24.0x.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $525M | $492M | $644M | $591M | $937M | $1.4B | $1.2B | $988M | $930M | $560M | $472M |
| Enterprise Value | $589M | $555M | $798M | $794M | $1.1B | $1.5B | $1.1B | $1.0B | $942M | $600M | $521M |
| P/E Ratio → | 78.59 | 73.07 | — | — | 1027.82 | 728.23 | 380.47 | 729.32 | 123.92 | — | 42.16 |
| P/S Ratio | 2.11 | 1.98 | 2.67 | 2.73 | 4.28 | 7.38 | 9.32 | 8.40 | 9.01 | 5.82 | 5.04 |
| P/B Ratio | 2.84 | 2.64 | 4.03 | 4.06 | 2.38 | 3.45 | 3.07 | 4.49 | 8.35 | 5.63 | 4.82 |
| P/FCF | 12.27 | 11.49 | 15.23 | 14.22 | 39.96 | 39.08 | 35.57 | 39.43 | 31.74 | 25.42 | — |
| P/OCF | 12.27 | 11.49 | 13.76 | 13.39 | 33.47 | 34.67 | 33.66 | 37.21 | 30.43 | 22.55 | 60.86 |
P/E links to full P/E history page with 30-year chart
MLAB EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Mesa Laboratories, Inc.'s enterprise value stands at 14.1x EBITDA, 51% below its 5-year average of 28.5x. The Technology sector median is 16.7x, placing the stock at a 16% discount on an enterprise-value basis.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.23 | 3.31 | 3.67 | 4.98 | 8.31 | 8.44 | 8.91 | 9.14 | 6.24 | 5.56 |
| EV / EBITDA | 14.09 | 13.29 | 19.54 | — | 29.90 | 51.45 | 37.66 | 50.12 | 48.94 | 51.52 | 20.78 |
| EV / EBIT | 31.80 | 30.00 | 44.80 | — | 248.79 | 205.33 | 109.47 | 111.92 | 109.26 | 278.74 | 31.92 |
| EV / FCF | — | 12.96 | 18.87 | 19.10 | 46.50 | 44.02 | 32.23 | 41.83 | 32.16 | 27.27 | — |
MLAB Profitability
Margins and return-on-capital ratios measuring operating efficiency
Mesa Laboratories, Inc. earns an operating margin of 7.4%. Operating margins have expanded from -125.9% to 7.4% over the past 3 years, signaling improving operational efficiency. ROE of 3.9% is modest. ROIC of 4.9% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.5% | 63.5% | 62.6% | 61.6% | 61.0% | 59.2% | 65.0% | 55.5% | 59.1% | 56.8% | 56.8% |
| Operating Margin | 7.4% | 7.4% | 6.8% | -125.9% | 1.5% | 2.6% | 9.2% | 6.7% | 9.5% | 2.3% | 17.4% |
| Net Profit Margin | 2.7% | 2.7% | -0.8% | -117.6% | 0.4% | 1.0% | 2.4% | 1.5% | 7.3% | -3.1% | 11.9% |
Return on Capital
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 3.9% | 3.9% | -1.3% | -94.4% | 0.2% | 0.5% | 1.0% | 1.1% | 7.1% | -3.0% | 12.3% |
| ROA | 1.6% | 1.6% | -0.4% | -45.9% | 0.1% | 0.3% | 0.6% | 0.6% | 4.7% | -1.8% | 6.7% |
| ROIC | 4.9% | 4.9% | 3.7% | -45.6% | 0.4% | 0.8% | 3.3% | 2.9% | 5.6% | 1.1% | 9.0% |
| ROCE | 5.8% | 5.8% | 4.9% | -53.3% | 0.5% | 0.8% | 2.6% | 3.0% | 7.0% | 1.4% | 11.2% |
MLAB Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Mesa Laboratories, Inc. carries a Debt/EBITDA ratio of 2.2x, which is manageable (27% below the sector average of 2.9x). Net debt stands at $63M ($90M total debt minus $27M cash).
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.48 | 0.48 | 1.14 | 1.59 | 0.47 | 0.56 | 0.36 | 0.64 | 0.20 | 0.47 | 0.56 |
| Debt / EBITDA | 2.16 | 2.16 | 4.44 | — | 5.11 | 7.43 | 4.89 | 6.76 | 1.18 | 3.97 | 2.19 |
| Net Debt / Equity | — | 0.34 | 0.96 | 1.40 | 0.39 | 0.44 | -0.29 | 0.27 | 0.11 | 0.41 | 0.50 |
| Net Debt / EBITDA | 1.51 | 1.51 | 3.77 | — | 4.20 | 5.77 | -3.90 | 2.87 | 0.65 | 3.50 | 1.96 |
| Debt / FCF | — | 1.48 | 3.64 | 4.89 | 6.54 | 4.94 | -3.34 | 2.39 | 0.43 | 1.85 | — |
| Interest Coverage | — | — | 1.50 | -47.38 | 0.92 | 1.92 | 1.29 | 1.70 | — | 1.16 | — |
MLAB Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.72x means Mesa Laboratories, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 2.47x to 1.72x over the past 3 years.
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.72 | 1.72 | 0.63 | 2.47 | 2.74 | 2.59 | 9.32 | 4.72 | 1.42 | 1.85 | 2.16 |
| Quick Ratio | 1.72 | 1.72 | 0.47 | 1.73 | 1.94 | 2.07 | 8.98 | 4.17 | 1.13 | 1.32 | 1.32 |
| Cash Ratio | 0.44 | 0.44 | 0.17 | 0.64 | 0.76 | 1.03 | 8.10 | 3.13 | 0.43 | 0.32 | 0.35 |
| Asset Turnover | — | 0.58 | 0.56 | 0.48 | 0.33 | 0.26 | 0.22 | 0.28 | 0.66 | 0.59 | 0.55 |
| Inventory Turnover | — | — | 3.55 | 2.54 | 2.46 | 3.06 | 4.20 | 3.68 | 6.23 | 4.50 | 2.91 |
| Days Sales Outstanding | — | 64.61 | 63.57 | 65.94 | 70.89 | 81.63 | 64.82 | 65.54 | 44.29 | 54.28 | 55.80 |
MLAB Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Mesa Laboratories, Inc. returns 0.7% to shareholders annually primarily through dividends. A payout ratio of 52.5% is moderate and appears sustainable, balancing shareholder returns with reinvestment capacity. The earnings yield of 1.3% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.7% | 0.7% | 0.5% | 0.6% | 0.4% | 0.2% | 0.3% | 0.3% | 0.3% | 0.4% | 0.5% |
| Payout Ratio | 52.5% | 52.5% | — | — | 366.2% | 178.5% | 96.7% | 153.1% | 32.9% | — | 21.1% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.3% | 1.4% | — | — | 0.1% | 0.1% | 0.3% | 0.1% | 0.8% | — | 2.4% |
| FCF Yield | 8.2% | 8.7% | 6.6% | 7.0% | 2.5% | 2.6% | 2.8% | 2.5% | 3.2% | 3.9% | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.7% | 0.7% | 0.5% | 0.6% | 0.4% | 0.2% | 0.3% | 0.3% | 0.8% | 0.4% | 0.5% |
| Shares Outstanding | — | $6M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $4M |
Peer Comparison
Compare MLAB with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 MLABYou | $525M | 78.6 | 14.1 | 12.3 | 63.5% | 7.4% | 3.9% | 4.9% | 2.2 |
 NEOG | $2B | -1.9 | 20.8 | — | 47.1% | 1.1% | -41.9% | 0.2% | 6.8 |
 LFUS | $12B | -165.5 | 90.6 | 33.1 | 38.0% | 1.6% | -3.0% | 1.0% | 6.8 |
 NOVT | $6B | 105.6 | 30.7 | 114.2 | 41.6% | 11.9% | 5.2% | 7.4% | 1.9 |
 RGEN | $7B | 153.5 | 54.7 | 79.3 | 47.1% | 8.1% | 2.4% | 2.2% | 5.0 |
 TRMB | $12B | 28.1 | 16.2 | 87.4 | 68.3% | 16.9% | 7.3% | 6.8% | 1.8 |
 BIO | $8B | 10.1 | 18.1 | 20.4 | 52.0% | 10.5% | 10.8% | 2.6% | 3.2 |
 IDXX | $45B | 43.0 | 31.1 | 42.4 | 61.8% | 31.6% | 66.2% | 42.5% | 0.7 |
 BRKR | $9B | -381.5 | 22.9 | 201.2 | 45.9% | 6.9% | -0.4% | 4.4% | 4.5 |
 FELE | $5B | 32.1 | 14.4 | 23.8 | 35.5% | 12.7% | 11.3% | 14.7% | 0.8 |
 OSIS | $4B | 25.6 | 16.3 | 65.5 | 34.3% | 12.7% | 16.5% | 11.5% | 2.6 |
| Technology Median | — | 29.0 | 16.7 | 19.2 | 48.8% | 0.2% | 1.6% | 2.7% | 2.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
MLAB — Frequently Asked Questions
Quick answers to the most common questions about buying MLAB stock.
What is Mesa Laboratories, Inc.'s P/E ratio?
Mesa Laboratories, Inc.'s current P/E ratio is 78.6x. The historical average is 25.1x. This places it at the 96th percentile of its historical range.
What is Mesa Laboratories, Inc.'s EV/EBITDA?
Mesa Laboratories, Inc.'s current EV/EBITDA is 14.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.4x.
What is Mesa Laboratories, Inc.'s ROE?
Mesa Laboratories, Inc.'s return on equity (ROE) is 3.9%. The historical average is 9.0%.
Is MLAB stock overvalued?
Based on historical data, Mesa Laboratories, Inc. is trading at a P/E of 78.6x. This is at the 96th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is Mesa Laboratories, Inc.'s dividend yield?
Mesa Laboratories, Inc.'s current dividend yield is 0.67% with a payout ratio of 52.5%.
What are Mesa Laboratories, Inc.'s profit margins?
Mesa Laboratories, Inc. has 63.5% gross margin and 7.4% operating margin.
How much debt does Mesa Laboratories, Inc. have?
Mesa Laboratories, Inc.'s Debt/EBITDA ratio is 2.2x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.